UK Regulator Won't Refer Thermo Fisher's Acquisition of PPD for Further Review
03 Dezembro 2021 - 4:47AM
Dow Jones News
By Jaime Llinares Taboada
The U.K. Competition and Markets Authority said Friday that it
has decided it won't refer Thermo Fisher Scientific Inc.'s planned
$17.4 billion acquisition of pharmaceutical-testing company PPD
Inc. to a phase 2 investigation.
The regulator had announced a probe into the deal in October, to
see if it would lead to a lessening of competition.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
December 03, 2021 02:32 ET (07:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
